FINANZMARKTNACHRICHTEN – With venture capital to the forefront of the life sciences: Young, innovative start-up companies turn ideas and findings from life science research into new treatments and medicines. However, in order to successfully bring these to market, they need important resources. Among other things, they need risk capital, i.e. venture capital funds (VCs), which help promising start-ups with capital and know-how for their development. But for the model to work in the long term, the economic success of one company must compensate for the losses of the others. Rainer Westermann explains the connections. Read more.